Fundraising Fox
Convergentgenomics
Founded 2015 · 25 employees on LinkedIn · 1 known investors
Find your way into Convergentgenomics
Sign up to see every warm intro you have to Convergentgenomics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Convergentgenomics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.
Founders & leadership
Convergentgenomics was founded in 2015 by Trevor Levin.
TL
Trevor LevinFounder, President & Chief Scientific OfficerTrevor Levin is founder and chief scientific officer of Convergent Genomics, a genomic diagnostics company developing next-generation sequencing and liquid biopsy tests for early detection of urothelial cancer. His expertise spans genomic analysis, computational biology, and drug response prediction applied to cancer diagnostics and treatment development.
BM
Brian MazzarellaChief Medical Officer
IH
Iden HaddadzadehChief Operating Officer
Investors · 1
Related companies · 2
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
UbieUbie provides a free AI-powered symptom checker that generates a personalized report on possible causes of a user's symptoms and guidance on when to see a doctor, based on a short questionnaire developed with doctors. The consumer-facing digital health service operates in Japan, the United States, and other countries.
Companies working in the same space as Convergentgenomics.
Frequently asked questions
- What does Convergentgenomics do?
- Convergent Genomics is a genomic diagnostics company that uses next-generation sequencing and liquid biopsy to extract DNA from urine and detect, monitor, and predict urothelial (bladder) cancer non-invasively. Its test targets earlier cancer recurrence detection for clinicians and patients.
- Who founded Convergentgenomics?
- Convergentgenomics was founded by Trevor Levin in 2015.
- Who are Convergentgenomics's investors?
- Convergentgenomics's investors include Civilization Ventures Management, Llc.